A Low Rate of Central Nervous System Progression in a Phase II Trial of Outpatient Chemobiologic Therapy With Cisplatin, Temozolomide, Interleukin-2, and Interferon Alfa 2-B for Metastatic Malignant Melanoma
Ready, Neal, Aronson, Frederick, Wanebo, Harold, Kennedy, TheresaVolume:
28
Language:
english
Journal:
American Journal of Clinical Oncology
DOI:
10.1097/01.coc.0000164006.72694.1b
Date:
October, 2005
File:
PDF, 225 KB
english, 2005